scholarly journals Factors that affect opioid use for postpartum pain control in women with opioid use disorder

2022 ◽  
Vol 226 (1) ◽  
pp. S133-S134
Author(s):  
Omar Abuzeid ◽  
Cassandra Heiselman ◽  
Anna Fuchs ◽  
Lama R. Noureddine ◽  
Mia A. Heiligenstein ◽  
...  
Keyword(s):  
Pain Control ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Postpartum Pain

scholarly journals Perioperative Management of a Patient Taking Suboxone® at the Time of Ambulatory Surgery

2020 ◽  
Vol 2020 ◽  
pp. 1-5
Author(s):  
Shawn H. Malan ◽  
Christopher H. Bailey ◽  
Narjeet Khurmi
Keyword(s):  
Postoperative Pain ◽  
Minimally Invasive ◽  
Pain Control ◽  
Perioperative Management ◽  
Ambulatory Surgery ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Postoperative Pain Control ◽  
Recovery Unit ◽  
Postanesthesia Recovery

In 2016, more than 11 million people reported misuse of opioids in the previous year. In an effort to combat opioid use disorder (OUD), the use of agonist/antagonist is becoming increasingly common, with more than 2.2 million patients reporting use of a buprenorphine containing medication such as Suboxone®. Buprenorphine is a unique opioid which acts as a partial μ agonist and ĸ antagonist. These properties make it an effective tool in treating OUD and abuse. However, despite its advantages in treating OUD and abuse, buprenorphine can make it difficult to control acute perioperative pain. We present a case in which the Mayo Clinic Arizona protocol for patients undergoing minimally invasive ambulatory surgery while taking Suboxone® is successfully executed, resulting in adequate postoperative pain control and timely discharge from the postanesthesia recovery unit.

scholarly journals Opioid Therapy in Cancer Patients and Survivors at Risk of Addiction, Misuse or Complex Dependency

2021 ◽  
Vol 2 ◽  
Author(s):  
Joseph V. Pergolizzi ◽  
Peter Magnusson ◽  
Paul J. Christo ◽  
Jo Ann LeQuang ◽  
Frank Breve ◽  
...  
Keyword(s):  
Mental Health ◽  
Cancer Patients ◽  
Pain Control ◽  
Opioid Therapy ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Delivery Of Care ◽  
Clinician Education ◽  
Individualized Approach ◽  
Decision Making Model

A clinical conundrum can occur when a patient with active opioid use disorder (OUD) or at elevated risk for the condition presents with cancer and related painful symptoms. Despite earlier beliefs that cancer patients were relatively unaffected by opioid misuse, it appears that cancer patients have similar risks as the general population for OUD but are more likely to need and take opioids. Treating such patients requires an individualized approach, informed consent, and a shared decision-making model. Tools exist to help stratify patients for risk of OUD. While improved clinician education in pain control is needed, patients too need to be better informed about the risks and benefits of opioids. Patients may fear pain more than OUD, but opioids are not always the most effective pain reliever for a given patient and some patients do not tolerate or want to take opioids. The association of OUD with mental health disorders (dual diagnosis) can also complicate delivery of care as patients with mental health issues may be less adherent to treatment and may use opioids for “chemical coping” as much as for pain control.

scholarly journals 677 Post cesarean pain control for patients with opioid use disorder: how are we doing?

2021 ◽  
Vol 224 (2) ◽  
pp. S425-S426
Author(s):  
Rebecca Rimsza ◽  
Ebony B. Carter ◽  
Nandini Raghuraman ◽  
Hayley Friedman ◽  
Katherine Massa ◽  
...  
Keyword(s):  
Pain Control ◽  
Opioid Use Disorder ◽  
Opioid Use

A case report of satisfactory post-left knee replacement pain control after switching from oxycodone to buprenorphine

2021 ◽  
Vol 17 (7) ◽  
pp. 179-182
Author(s):  
Shuo Qiu, MD ◽  
Sachinder Vasudeva, MD
Keyword(s):  
Case Report ◽  
Knee Replacement ◽  
Pain Control ◽  
Lower Risk ◽  
Discharge Planning ◽  
Opioid Use Disorder ◽  
Left Knee ◽  
Opioid Use ◽  
Pain Medications ◽  
Daily Urine

This case report demonstrates using buprenorphine 32 mg to achieve adequate pain control after a total knee replacement. The patient stopped buprenorphine 48 hours before surgery. He was prescribed 150 tablets of oxycodone 5 mg. After finishing oxycodone, he experienced significant pain that was relieved by 32 mg of buprenorphine daily. Urine drug screens were negative perioperatively. Patients with opioid use disorder require careful discharge planning to avoid opioid relapses or misuses of pain medications. Buprenorphine offers many unique advantages in acute pain control, including lower risk of respiratory depression, abuse potential, and lower risk of nephrotoxicity.

L'esperienza clinica con Levometadone nel trattamento del disturbo da uso di oppiacei

MISSION ◽  
2019 ◽  
pp. 54-57
Author(s):  
Marco Riglietta ◽  
Paolo Donadoni ◽  
Grazia Carbone ◽  
Caterina Pisoni ◽  
Franca Colombi ◽  
...  
Keyword(s):  
Adverse Events ◽  
Real Life ◽  
Opioid Use Disorder ◽  
Racemic Mixture ◽  
Opioid Use ◽  
The Real ◽  
New Formulation

In Italy, at the end of the 1970s, methadone hydrochloride was introduced for the treatment of opioid use disorder, in the form of a racemic mixture consisting of levomethadone and dextromethadone.In 2015 Levometadone was introduced, a new formulation marketed in Italy for the treatment of opioid use disorder in 2015.The article aims to bring the experience of an Italian Addiction Centre back to the use of this new formulation in the "real life" analyzing the efficacy, the trend of adverse events and pharmacological iterations in a context in which the treated population often uses besides the opiates, cocaine and alcohol, are burdened by a relevant physical and psychic comorbidity and frequently have a prescribed polypharmacy.

Sign in / Sign up

Export Citation Format

Share Document